✦ LIBER ✦

A Combination Therapy of Donepezil and Cilostazol for Patients With Moderate Alzheimer Disease: Pilot Follow-Up Study

✍ Scribed by Arai, Heii; Takahashi, Tadashi

Book ID: 123489521
Publisher: American Psychiatric Publishing Inc
Year: 2009
Tongue: English
Weight: 59 KB
Volume: 17
Category: Article
ISSN: 1064-7481
DOI: 10.1097/JGP.0b013e31819431ea

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SPECT Follow-Up Study of Cerebral Blood

SPECT Follow-Up Study of Cerebral Blood Flow Changes During Donepezil Therapy in Patients with Alzheimer's Disease

✍ Soichiro Shimizu; Haruo Hanyu; Toshihiko Iwamoto; Kiyoshi Koizumi; Kimihiko Abe 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

Memantine in patients with Alzheimer's d

Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy

✍ Atri, Alireza; Molinuevo, JosÃ© L; Lemming, Ole; Wirth, Yvonne; Pulte, Irena; Wi 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 426 KB

P.4.044 Long-term efficacy of donepezil

P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

✍ B. Winblad; A. Wimo; A.-L. Wetterholm; A. Haglund; K. Engedal; H. Soininen; F.R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Effects of cilostazol on cognition and r

Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: A pilot study

✍ Hirofumi Sakurai; Haruo Hanyu; Tomohiko Sato; Kazumasa Kume; Kentaro Hirao; Hide 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This

Acceptability, safety and feasibility of

Acceptability, safety and feasibility of aerobic exercise in patients with mild-to-moderate ALZHEIMER'S disease: A pilot study

✍ Frederiksen, Kristian; Sobol, Nanna; Beyer, Nina; Madsen, Karine; Law, Ian; Gard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 116 KB